137 related articles for article (PubMed ID: 8009007)
1. [Autoimmune biological anomalies in 35 patients with chronic viral hepatitis C treated over 6 months with interferon and followed-up over a year].
Marcais O; Hanslik B; Coste F; Perney P; Clot J; Blanc F
Rev Med Interne; 1993; 14(10):1009. PubMed ID: 8009007
[TBL] [Abstract][Full Text] [Related]
2. Autoimmunity during alpha-interferon therapy for chronic hepatitis C.
Yoshikawa M; Sakamoto T; Mitoro A; Mochi T; Tsujii H; Koizumi M; Yoshiji H; Sakaguchi Y; Fukui H; Nakano H
Gastroenterol Jpn; 1993 May; 28 Suppl 5():109-14. PubMed ID: 8359620
[TBL] [Abstract][Full Text] [Related]
3. Development of transient autoimmune hepatitis during interferon treatment of chronic hepatitis B.
Cianciara J; Laskus T
Dig Dis Sci; 1995 Aug; 40(8):1842-4. PubMed ID: 7648989
[TBL] [Abstract][Full Text] [Related]
4. Interferon alpha treatment of chronic hepatitis C in patients with evidence for co-existent autoimmune dysregulation.
Van Thiel DH; Molloy PJ; Friedlander L; Kania RJ; Fagiuoli S; Caraceni P; Wright HI; Zuhdi N
Hepatogastroenterology; 1995; 42(6):900-6. PubMed ID: 8847043
[TBL] [Abstract][Full Text] [Related]
5. Thyroid autoimmune disorders in patients with chronic hepatitis C before and during interferon-alpha therapy.
Marazuela M; García-Buey L; González-Fernández B; García-Monzón C; Arranz A; Borque MJ; Moreno-Otero R
Clin Endocrinol (Oxf); 1996 Jun; 44(6):635-42. PubMed ID: 8759175
[TBL] [Abstract][Full Text] [Related]
6. Antithyroid peroxidase antibody and development of silent thyroiditis during interferon-alpha 2a treatment of chronic hepatitis C.
Wada M; Shimoyama T; Hamada A; Fukuchi M
Am J Gastroenterol; 1995 Aug; 90(8):1366-7. PubMed ID: 7639264
[No Abstract] [Full Text] [Related]
7. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
[TBL] [Abstract][Full Text] [Related]
8. Chronic hepatitis C complicated by Coombs-negative hemolytic anemia during interferon treatment.
Hirashima N; Mizokami M; Orito E; Yamauchi M; Narita M; Mizuno M; Tokuda Y; Nakano T; Kato M; Matsumoto T
Intern Med; 1994 May; 33(5):300-2. PubMed ID: 7949634
[TBL] [Abstract][Full Text] [Related]
9. Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A.
Castenskiold EC; Colvin BT; Kelsey SM
Br J Haematol; 1994 Jun; 87(2):434-6. PubMed ID: 7947296
[TBL] [Abstract][Full Text] [Related]
10. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection.
Schlesinger TE; Camisa C; Gay JD; Bergfeld WF
J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):1023-5. PubMed ID: 9204077
[No Abstract] [Full Text] [Related]
11. [Lichen planus during chronic hepatitis C treated with interferon alpha].
d'Agay-Abensour L; Benamouzig R; de Belilovsky C; Cordoliani F; Halphen M; Rambaud JC
Gastroenterol Clin Biol; 1992; 16(6-7):610-1. PubMed ID: 1526425
[No Abstract] [Full Text] [Related]
12. Differentiation between autoimmune hepatitis and hepatitis C virus related liver disease.
Heintges T; Niederau C
Z Gastroenterol; 1993 May; 31(5):285-8. PubMed ID: 7686702
[TBL] [Abstract][Full Text] [Related]
13. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
Chung YH; Shong YK
Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
[TBL] [Abstract][Full Text] [Related]
14. Why we should treat chronic viral hepatitis.
King PD
Postgrad Med; 1996 Sep; 100(3):68-70, 73; discussion 73, 78. PubMed ID: 8795647
[No Abstract] [Full Text] [Related]
15. [Autoimmune thrombocytopenic purpura after treatment of chronic viral hepatitis C with interferon].
Maïga MY; Oberti F; Foussard C; Calès P
Gastroenterol Clin Biol; 1995; 19(8-9):739-40. PubMed ID: 8522132
[No Abstract] [Full Text] [Related]
16. [Hepatitis C and immunologic anomalies].
Lunel F
Gastroenterol Clin Biol; 1994; 18(10):829-38. PubMed ID: 7875390
[No Abstract] [Full Text] [Related]
17. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
[TBL] [Abstract][Full Text] [Related]
18. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.
Nishiguchi S; Kuroki T; Nakatani S; Morimoto H; Takeda T; Nakajima S; Shiomi S; Seki S; Kobayashi K; Otani S
Lancet; 1995 Oct; 346(8982):1051-5. PubMed ID: 7564784
[TBL] [Abstract][Full Text] [Related]
20. MALT non-Hodgkin's lymphoma associated with hepatitis C virus infection treated by interferon alpha.
Bauduer F
Am J Hematol; 1996 Nov; 53(3):209. PubMed ID: 8895702
[No Abstract] [Full Text] [Related]
[Next] [New Search]
